Raymond James & Associates’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,054
Closed -$106K 3974
2022
Q2
$106K Sell
25,054
-5,587
-18% -$39.2K ﹤0.01% 3672
2022
Q1
$347K Buy
+30,641
New +$354K ﹤0.01% 3317

Other funds holding CGNT

Raymond James & Associates's CGNT Position: Q3 2022 in Review

Raymond James & Associates sold out of Cognyte Software (CGNT) in Q3 2022, closing a stake of 25,054 shares — an estimated $106K sold.

Raymond James & Associates first reported a position in CGNT in Q1 2022 and held it in 2 quarters. The position peaked at $347K in Q1 2022. 124 funds tracked by Wall St. Rank hold CGNT as of Q3 2022.

  • Raymond James & Associates reported no remaining Cognyte Software position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 25,054 Cognyte Software shares in Q3 2022, an estimated $106K.
  • Raymond James & Associates first reported a position in Cognyte Software in Q1 2022 and held it in 2 quarters.
  • Raymond James & Associates's Cognyte Software position peaked at $347K in Q1 2022.
  • 124 funds tracked by Wall St. Rank held Cognyte Software as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.